PML case confirmed in someone taking Gilenya

Posted by & filed under MS News.

Source MS Society:

Novartis, who manufacture Gilenya (fingolimod), have confirmed a case of the rare brain infection PML (progressive multifocal leukoencephalopathy) in someone taking the drug.  Read on.